Searched for
THERAPEUTICS
A rare-book dealer acquired a medieval manuscript filled with strange writing in 1912; 114 years later, no decipherment has won broad acceptanceThe Voynich Manuscript is one of history's greatest unsolved mysteries. The medieval document, illustrated and bought in 1912 by rare-book ...- Ministry of Science signs MoU with Peptris for collab in AI-based drug discovery and developmentThe Ministry of Science has entered into a partnership with Peptris Technologies to bolster drug development under the initiative called VI...
- 5 stocks with consistent score improvement and upside potential of up to 34% in 1 year, according to analystsGiven the current global and domestic situation, the chances are that the volatility quotient in the market will remain high. So, the best ...
- IPO Watch: Want to invest in Initial Public Offering? Know this factor before buying sharesIPO tracker: Australia's Nvidia-backed AI data centre operator Firmus withdrew its planned stock market listing on the bourse in October, c...
- When nothing is cheap, winners may come from any corner: 19 stocks with downside to upside potential of -28% to plus 22%Because each pharma company took a different road, they no longer rise and fall together. Where any one of them stands in 10 years depends ...
- Reliance, PepsiCo, Monster get court breather over Campa ‘energy drink’ label banFSSAI's order barring Reliance Industries from selling its Campa beverages as “energy drinks” has been put on hold. This is an interim reli...
- Centre may seek legal view on licensing of sterile drugsThe government is actively exploring a proposal to expand central licensing authority over all sterile drug products following a recent Sup...
- The Nobel-winning breakthrough that turned light into a remote control for the brain, allowing scientists to switch neurons on and offOptogenetics, a groundbreaking technique, enables researchers to control specific neurons using light, providing insights into brain functi...
- Ayush services sector supports 1.76 million livelihoods; women constitute 43% of the workforceThe Ayush services sector supports 1.76 million livelihoods in India and has a significant female workforce. Women's participation in organ...
- Halle Berry’s ex-husband Olivier Martinez accuses her of physically abusing their 12-year-old son, she calls the claims ‘meritless’Berry’s ex-husband, Martinez, accused her of physically abusing their 12-year-old son and choking him during an argument at her home. Berry...
- Pete Hegseth creates Pentagon Office of Religious Affairs reporting directly to himDefense Secretary Pete Hegseth is establishing a new Office of Religious Affairs to provide religious support. The office will report direc...
- Why is Liquidia stock plunging? Yutrepia patent case explainedLiquidia shares plunged nearly 50% after a US court ruled against the company in a patent dispute with United Therapeutics, raising concern...
- Why is Liquidia share price falling by nearly 50% today? US federal court ruling linked to lung drug Yutrepia explainedLiquidia stock dropped after a US federal court ruled that Liquidia's Yutrepia lung drug infringes two claims of a United Therapeutics pate...
- ChrysCapital to take minority stake in Linux laboratoriesLinux Laboratories has secured $70 million in equity funding from ChrysCapital and Tata Capital Healthcare Fund III. This investment involv...
- Why is Summit Therapeutics share price up today by 22%?Summit Therapeutics share price is up today by 22% after biopharma firm announced AstraZeneca would invest $2 billion in it. British drugma...
- Anupam Rasayan completes Bliss GVS deal, targets Rs 4,000-crore integrated platformAnupam Rasayan India Limited has finalised its acquisition of a controlling interest in Bliss GVS Pharma, marking a strategic expansion int...
- Sun Pharma signs major deal with LIB Therapeutics of US, gains access to $3.7-bn global market for bad cholesterol inhibitor PCSK9Sun Pharma has signed an exclusive agreement with LIB Therapeutics for Lerodalcibep, a cholesterol-lowering medication. This deal covers al...
- Ayush services sector growing fast; projected to hit up to USD 318 billion by 2047: StudyThe Ayush services sector is projected to reach USD 216-318 billion by 2047 as it continues to expand. This sector reported a 16.91 percent...
- Vitruvias Therapeutics thyroid tablet recall gets FDA’s highest-risk rating - here’s what to check and what patients need to knowA thyroid medicine recall has received the FDA’s highest-risk classification after testing found one lot of Thyroid Tablets, USP 30 mg coul...
- Vitruvias Therapeutics thyroid tablet recall: FDA issues serious Class I warning over ‘superpotent’ medicine — check lot number, expiration date and what patients should knowVitruvias Therapeutics thyroid tablet recall: The FDA has issued a serious Class I recall for one lot of Vitruvias Therapeutics thyroid tab...
Load More
